Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telcagepant (MK-0974) for Acute Migraine Treatment
NCT00483704Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telcagepant in migraine, sponsored by Merck & Co.. Started Aug 2008; status: completed.
02
Drugs
telcagepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00483704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483704.